These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22229080)

  • 1. Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.
    Cai S; Bagby TR; Forrest ML
    Ther Deliv; 2011 Nov; 2(11):1467-84. PubMed ID: 22229080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.
    Xie Y; Bagby TR; Cohen MS; Forrest ML
    Expert Opin Drug Deliv; 2009 Aug; 6(8):785-92. PubMed ID: 19563270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
    Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of intraperitoneal antineoplastic drug delivery.
    Markman M
    Cancer Treat Res; 2007; 134():153-69. PubMed ID: 17633052
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy.
    Shamsi M; Sedaghatkish A; Dejam M; Saghafian M; Mohammadi M; Sanati-Nezhad A
    Drug Deliv; 2018 Nov; 25(1):846-861. PubMed ID: 29589479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First clinical study of a pegylated diabody
    Scott AM; Akhurst T; Lee FT; Ciprotti M; Davis ID; Weickhardt AJ; Gan HK; Hicks RJ; Lee ST; Kocovski P; Guo N; Oh M; Mileshkin L; Williams S; Murphy D; Pathmaraj K; O'Keefe GJ; Gong SJ; Pedersen JS; Scott FE; Wheatcroft MP; Hudson PJ
    Theranostics; 2020; 10(25):11404-11415. PubMed ID: 33052222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and preclinical trials of isolated liver perfusion for advanced liver tumors: primary liver tumors.
    Lowy AM; Curley SA
    Surg Oncol Clin N Am; 1996 Apr; 5(2):429-41. PubMed ID: 9019362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity issues in cancer drug development.
    Gewirtz DA; Bristol ML; Yalowich JC
    Curr Opin Investig Drugs; 2010 Jun; 11(6):612-4. PubMed ID: 20496255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized chemotherapy.
    Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
    Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
    Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.
    Federico C; Sun J; Muz B; Alhallak K; Cosper PF; Muhammad N; Jeske A; Hinger A; Markovina S; Grigsby P; Schwarz JK; Azab AK
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1483-1494. PubMed ID: 33253820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.
    Stirland DL; Nichols JW; Miura S; Bae YH
    J Control Release; 2013 Dec; 172(3):1045-64. PubMed ID: 24096014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric drug delivery systems for localized cancer chemotherapy.
    De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
    Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model.
    Song SY; Kim KP; Jeong SY; Park J; Park J; Jung J; Chung HK; Lee SW; Seo MH; Lee JS; Jung KH; Choi EK
    Oncotarget; 2016 Nov; 7(47):77348-77357. PubMed ID: 27764799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors.
    Scaggiante B; Dapas B; Farra R; Grassi M; Pozzato G; Giansante C; Fiotti N; Tamai E; Tonon F; Grassi G
    Curr Drug Metab; 2013 Jun; 14(5):565-82. PubMed ID: 23687927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium.
    Bautista F; Moreno L; Marshall L; Pearson ADJ; Geoerger B; Paoletti X
    Eur J Cancer; 2017 Nov; 86():275-284. PubMed ID: 29055843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates.
    Jackson D; Stover D
    Pharm Res; 2015 Nov; 32(11):3458-69. PubMed ID: 25339341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local iontophoretic administration of cytotoxic therapies to solid tumors.
    Byrne JD; Jajja MR; O'Neill AT; Bickford LR; Keeler AW; Hyder N; Wagner K; Deal A; Little RE; Moffitt RA; Stack C; Nelson M; Brooks CR; Lee W; Luft JC; Napier ME; Darr D; Anders CK; Stack R; Tepper JE; Wang AZ; Zamboni WC; Yeh JJ; DeSimone JM
    Sci Transl Med; 2015 Feb; 7(273):273ra14. PubMed ID: 25653220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.